Viosera Therapeutics
Saint Louis
About Viosera Therapeutics
Viosera Therapeutics is a predict and block drug resistance in cancer and bacteria. The company discovers synergies between approved drugs and develop combinations of drugs that suppress resistance. Antibiotic resistance makes it necessary to develop better treatments for deadly infections. Viosera Therapeutics was founded in July 2016 and is headquartered in Sunnyvale, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $150.0K
- Funding stage: Seed
- Last round: Seed (Jan 2022)
- Website: viosera.com
Industries & Categories
Medical, Pharmaceutical, Therapeutics, Wellness
Social Profiles
Canonical: https://fsome.com/organization/viosera-therapeutics-109657 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.